Compound Detail
CHEMBL461101
ELTROMBOPAG 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\Nc1cccc(-c2cccc(C(=O)O)c2)c1O
Basic Information
| ChEMBL ID | CHEMBL461101 |
| Name | ELTROMBOPAG |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | XDXWLKQMMKQXPV-QYQHSDTDSA-N |
| Therapeutic | ✓ Yes |
9
Targets
19
Activities
4
Assay Types
13
PK Parameters
20
Publications
3
Known Names
20
Indications
Molecular Properties
442.5
MW (Da)
4.56
ALogP
6
HBA
3
HBD
114.6
PSA (Ų)
0.40
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2008 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Anemia, Aplastic Anemia, Aplastic Hemorrhage Hepatitis C Hepatitis C, Chronic Neoplasms Purpura, Thrombocytopenic, Idiopathic Thrombocytopenia Blood Platelet Disorders Fanconi Anemia Graft vs Host Disease Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Myeloid, Acute Liver Diseases Lymphoma Myelodysplastic Syndromes Wiskott-Aldrich Syndrome Anemia Liver Cirrhosis
ATC Classification
B02BX05
eltrombopag
Level 1: BLOOD AND BLOOD FORMING ORGANS
Level 2: ANTIHEMORRHAGICS
Activity Summary
IC50 11 meas. best 6.2
Ki 4 meas. best 5.07
EC50 2 meas. best 7.42
Kd 2 meas. best 4.88
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Thrombopoietin receptor CHEMBL1864 | EC50 | 7.42 | 7.42 | 38.0 | 2 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 6.2 | 6.18 | 631.0 | 2 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 CHEMBL5393 | IC50 | 5.51 | 5.51 | 3100.0 | 1 |
| METTL3/METTL14 CHEMBL4106140 | IC50 | 5.44 | 5.4067 | 3650.0 | 3 |
| SARS-CoV-2 CHEMBL4303835 | IC50 | 5.08 | 5.08 | 8270.0 | 1 |
| Solute carrier organic anion transporter family member 2B1 CHEMBL1743124 | Ki | 5.07 | 5.07 | 8480.0 | 1 |
| METTL3/METTL14 CHEMBL4106140 | Kd | 4.88 | 4.88 | 13200.0 | 1 |
| N6-adenosine-methyltransferase catalytic subunit CHEMBL4739695 | Kd | 4.88 | 4.88 | 13200.0 | 1 |
| Solute carrier organic anion transporter family member 1B1 CHEMBL1697668 | Ki | 4.83 | 4.83 | 14900.0 | 1 |
| Solute carrier organic anion transporter family member 1B3 CHEMBL1743121 | Ki | 4.59 | 4.59 | 25600.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 0.38 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 0.0325 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 0.335 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 0.001167 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 0.2267 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 0.55 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 1.288 | mL.min-1.kg-1 | Mus musculus |
| CL | 0.92 | mL.min-1.kg-1 | Mus musculus |
| CL | 0.5717 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 0.03967 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 0.7467 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 40000.0 | nM | Mus musculus |
| Vd | 0.0411 | L.kg-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 21422191 | 10.1124/dmd.110.037960 | Hepatocyte | 17 |
| 21422191 | 10.1124/dmd.110.037960 | ADMET | 10 |
| 21422191 | 10.1124/dmd.110.037960 | Rattus norvegicus | 4 |
| 21422191 | 10.1124/dmd.110.037960 | Liver | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 21422191 | 10.1124/dmd.110.037960 | Solute carrier family 22 member 1 | 3 |
| 21422191 | 10.1124/dmd.110.037960 | Solute carrier organic anion transporter family member 1B3 | 3 |
| 21422191 | 10.1124/dmd.110.037960 | Solute carrier organic anion transporter family member 2B1 | 3 |
| 21422191 | 10.1124/dmd.110.037960 | Solute carrier organic anion transporter family member 1B1 | 3 |
| 36692498 | 10.1021/acs.jmedchem.2c01601 | METTL3/METTL14 | 3 |
| 25087753 | 10.1016/j.vascn.2014.07.002 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 3 |
| 25087753 | 10.1016/j.vascn.2014.07.002 | Voltage-gated potassium channel, IKs; KCNQ1(Kv7.1)/KCNE1(MinK) | 2 |
| 25087753 | 10.1016/j.vascn.2014.07.002 | Sodium channel protein type 5 subunit alpha | 2 |
| 25087753 | 10.1016/j.vascn.2014.07.002 | Voltage-dependent L-type calcium channel subunit alpha-1C | 2 |
| - | 10.6019/CHEMBL4495565 | Vero C1008 | 2 |
| 21422191 | 10.1124/dmd.110.037960 | Kidney | 2 |
| 21422191 | 10.1124/dmd.110.037960 | Mus musculus | 2 |
| 18778936 | 10.1016/j.bmcl.2008.08.068 | Thrombopoietin receptor | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 18783949 | 10.1016/j.bmcl.2008.08.077 | Thrombopoietin receptor | 2 |
Data from ChEMBL 36 via Core Engine